Amy Simon

CIK: 0001963879

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (58.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (41.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BEAM

Beam Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

BEAM
Beam Therapeutics Inc.
Jul 27, 2026
Sale(S)
Direct
16.7K shares at avg. $25.74$429K
BEAM
Beam Therapeutics Inc.
Jun 30, 2026
Sale(S)
Direct
373 shares at avg. $34.73$13K
BEAM
Beam Therapeutics Inc.
Apr 1, 2026
Sale(S)
Direct
6.7K shares at avg. $24.58$165K
BEAM
Beam Therapeutics Inc.
Mar 31, 2026
Award(A)
Direct
31.8K shares-
BEAM
Beam Therapeutics Inc.
Jan 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
88.5K shares-
BEAM
Beam Therapeutics Inc.
Dec 31, 2025
Award(A)
Direct
12.5K shares-
BEAM
Beam Therapeutics Inc.
Jul 3, 2025
Sale(S)
Direct
876 shares at avg. $20.12$18K
BEAM
Beam Therapeutics Inc.
Jul 1, 2025
Sale(S)
Direct
374 shares at avg. $16.94$6K
BEAM
Beam Therapeutics Inc.
Apr 2, 2025
Sale(S)
Direct
21K shares at avg. $17.73$372K
BEAM
Beam Therapeutics Inc.
Apr 1, 2025
Sale(S)
Direct
9.6K shares at avg. $18.35$176K
BEAM
Beam Therapeutics Inc.
Mar 31, 2025
Award(A)
Direct
27.5K shares-
BEAM
Beam Therapeutics Inc.
Jan 31, 2025
Award(A)
Stock Option (Right to Buy)
Direct
55K shares-

		Type	Shares	Price		Ownership
Jul 27, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	16,667	$25.74	$429,037	Direct
Jun 30, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	373	$34.73	$12,954	Direct
Apr 1, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	6,700	$24.58	$164,686	Direct
Mar 31, 2026	BEAM Beam Therapeutics Inc.	Award(A)	31,750	-	$0	Direct
Jan 31, 2026	BEAM Beam Therapeutics Inc.	Award(A) Stock Option (Right to Buy)	88,500	-	-	Direct
Dec 31, 2025	BEAM Beam Therapeutics Inc.	Award(A)	12,500	-	$0	Direct
Jul 3, 2025	BEAM Beam Therapeutics Inc.	Sale(S)	876	$20.12	$17,625	Direct
Jul 1, 2025	BEAM Beam Therapeutics Inc.	Sale(S)	374	$16.94	$6,336	Direct
Apr 2, 2025	BEAM Beam Therapeutics Inc.	Sale(S)	20,997	$17.73	$372,294	Direct
Apr 1, 2025	BEAM Beam Therapeutics Inc.	Sale(S)	9,566	$18.35	$175,542	Direct
Mar 31, 2025	BEAM Beam Therapeutics Inc.	Award(A)	27,500	-	-	Direct
Jan 31, 2025	BEAM Beam Therapeutics Inc.	Award(A) Stock Option (Right to Buy)	55,000	-	-	Direct

1-12 of 12 transactions

About Simon Amy

Simon Amy (SEC CIK 0001963879) files insider reports with the SEC as Chief Medical Officer of Beam Therapeutics Inc. (BEAM).

Signal8 holds 10 ownership filings by Simon Amy, all Form 4s, filed between Feb 3, 2025 and Jul 29, 2026. Those filings report 12 transactions, from Jan 31, 2025 to Jul 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Simon Amy's filings is in CAMBRIDGE, MA.

Recent filings by Simon Amy

Jul 27, 2026: Open-market sale of BEAM shares (Form 4, code S).
Jun 30, 2026: Open-market sale of BEAM shares (Form 4, code S).
Apr 1, 2026: Open-market sale of BEAM shares (Form 4, code S).
Mar 31, 2026: Grant or award of BEAM shares (Form 4, code A).
Jan 31, 2026: Grant or award of BEAM derivative securities (Form 4, code A).

Other insiders filing for Beam Therapeutics Inc. (BEAM)

Evans John M., CEO
Cavanagh Bethany J, SVP, Finance and Treasurer
Ciaramella Giuseppe, President
FMR LLC, 10% Owner
Shaw Christi, Director
Walsh Kathleen E, Director

How to read Form 4 transaction codes